← Back to Search

Device Therapy

CRT Optimization for Heart Failure (METEOR-CRT Trial)

N/A
Recruiting
Led By Alan J Bank, MD
Research Sponsored by Allina Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Pre-CRT EF less than or equal 40%
Age greater than or equal 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

METEOR-CRT Trial Summary

This trial looks to improve the effectiveness of a common heart failure treatment by using information from standard ECGs.

Who is the study for?
This trial is for adults over 18 with heart failure who are getting or have recently received their first CRT device and have a left ventricular ejection fraction of 40% or less. They must be on the best medication regimen, able to give informed consent, and not part of another study that could affect results.Check my eligibility
What is being tested?
The study aims to optimize cardiac resynchronization therapy (CRT) in new recipients by adjusting the device settings based on standard ECG readings. It seeks to improve heart function and quality of life in patients who often don't respond well to current CRT setups.See study design
What are the potential side effects?
While this trial focuses on reprogramming existing devices rather than testing new drugs, potential side effects may include discomfort from ECG procedures or skin reactions from electrode adhesives.

METEOR-CRT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My heart's pumping ability is 40% or less before treatment.
Select...
I am 18 years old or older.

METEOR-CRT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in left ventricular function
Change in left ventricular size
Other outcome measures
Correlation of change in electrical dyssynchrony and LVESV

METEOR-CRT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ECG CRT OptimizationExperimental Treatment1 Intervention
The experimental arm patients will have CRT device reprogrammed based on the ECG CRT optimization information for 12 months.
Group II: Standard CRT Programming, then ECG CRT OptimizationActive Control1 Intervention
The control arm patients will have standard CRT programming for the first 6 months, and then will be reprogrammed based on the ECG CRT optimization information for the following 6 months

Find a Location

Who is running the clinical trial?

Allina Health SystemLead Sponsor
57 Previous Clinical Trials
1,177,094 Total Patients Enrolled
5 Trials studying Heart Failure
3,160 Patients Enrolled for Heart Failure
Alan J Bank, MDPrincipal InvestigatorUnited Heart & Vascular - Allina Health System
4 Previous Clinical Trials
909 Total Patients Enrolled
4 Trials studying Heart Failure
909 Patients Enrolled for Heart Failure

Media Library

Reprogramming of CRT Device Settings (Device Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04083690 — N/A
Heart Failure Research Study Groups: Standard CRT Programming, then ECG CRT Optimization, ECG CRT Optimization
Heart Failure Clinical Trial 2023: Reprogramming of CRT Device Settings Highlights & Side Effects. Trial Name: NCT04083690 — N/A
Reprogramming of CRT Device Settings (Device Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04083690 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the age range for participation in this research project limited?

"Patients aged between 18 and 100 are eligible for this trial, while 22 sub-18 studies and 695 over 65 trials exist."

Answered by AI

Is it possible to join this medical experiment?

"Individuals with heart failure and systolic dysfunction, aged between 18 - 100 years old are eligible to participate in this clinical trial. The researchers aim to recruit a total of 120 participants."

Answered by AI

What is the aggregate enrollment of this medical investigation?

"Affirmative. Clinicaltrials.gov substantiates that, as of June 8th 2022, this clinical trial is actively enrolling 120 patients from two distinct medical facilities. This research was first announced on October 11th 2019."

Answered by AI

Is this research endeavor still open for enrollment?

"Information found on clinicaltrials.gov reveals that this experiment is still looking for volunteers. The trial was first made public on October 11th 2019 and underwent its last revision on June 8th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Florida
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients
Alan J. Bank, MD 2019. "Multi-lead ECG to Effectively Optimize Resynchronization Devices: New CRT Recipients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04083690.
~22 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top